Abstract
Background
Obesity and fatty-liver disease are increasingly common in children. Hepatic steatosis is becoming the most common cause of chronic liver disease during childhood. There is a need for noninvasive imaging methods that are easily accessible, safe and do not require sedation in the diagnosis and follow-up of the disease.
Objective
In this study, the diagnostic role of ultrasound attenuation imaging (ATI) in the detection and staging of fatty liver in the pediatric age group was investigated using the magnetic resonance imaging (MRI)-proton density fat fraction as the reference.
Materials and methods
A total of 140 children with both ATI and MRI constituted the study group. Fatty liver was classified as mild (S1, defined as ≥ 5% steatosis), moderate (S2, defined as ≥ 10% steatosis), or severe (S3, defined as ≥ 20% steatosis) according to MRI-proton density fat fraction values. MRI studies were performed on the same 1.5-tesla (T) MR device without sedation and contrast agent. Ultrasound examinations were performed independently by two radiology residents blinded to the MRI data.
Results
While no steatosis was detected in half of the cases, S1 steatosis was found in 31 patients (22.1%), S2 in 29 patients (20.7%) and S3 in 10 patients (7.1%). A strong correlation was found between attenuation coefficient and MRI-proton density fat fraction values (r = 0.88, 95% CI 0.84–0.92; P < 0.001). The area under the receiver operating characteristic curve values of ATI were calculated as 0.944 for S > 0, 0.976 for S > 1 and 0.970 for S > 2, based on 0.65, 0.74 and 0.91 dB/cm/MHz cut-off values, respectively. The intraclass correlation coefficient values for the inter-observer agreement and test–retest reproducibility were calculated as 0.90 and 0.91, respectively.
Conclusion
Ultrasound attenuation imaging is a promising noninvasive method for the quantitative evaluation of fatty liver disease.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig8_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00247-023-05615-8/MediaObjects/247_2023_5615_Fig9_HTML.png)
Similar content being viewed by others
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to privacy or ethical restrictions.
Change history
18 March 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00247-023-05643-4
References
Vos MB, Abrams SH, Barlow SE et al (2017) NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64:319–334
Faienza MF, Chiarito M, Molina-Molina E et al (2020) Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World J Pediatr 16:438–445
Anderson EL, Howe LD, Jones HE et al (2015) The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS ONE 10:e0140908
Awai HI, Newton KP, Sirlin CB et al (2014) Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 12:765–773
Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97
Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431
Bannas P, Kramer H, Hernando D et al (2015) Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 62:1444–1455
Bray TJ, Chouhan MD, Punwani S et al (2018) Fat fraction map** using magnetic resonance imaging: insight into pathophysiology. Br J Radiol 91:20170344
Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68:763–772
Schwimmer JB, Middleton MS, Behling C et al (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61:1887–1895
Tada T, Nishimura T, Yoshida M (2001) Iijima H (2020) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography. J Med Ultrason 47:511–520
Cailloce R, Tavernier E, Brunereau L et al (2021) Liver shear wave elastography and attenuation imaging coefficient measures: prospective evaluation in healthy children. Abdom Radiol (NY) 46:4629–4636
D’Hondt A, Rubesova E, **e H et al (2021) Liver fat quantification by ultrasound in children: a prospective study. AJR Am J Roentgenol 217:996–1006
Berardis S, Sokal E (2014) Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr 173:131–139
Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189:W320–323
Dioguardi Burgio M, Ronot M, Reizine E et al (2020) Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort. Eur Radiol 30:2293–2301
Ferraioli G, Soares Monteiro LB (2019) Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol 25:6053–6062
Chauhan A, Sultan LR, Furth EE et al (2016) Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis. J Clin Ultrasound 44:580–586
Karlas T, Petroff D, Sasso M et al (2017) Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 66:1022–1030
Desai NK, Harney S, Raza R et al (2016) Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients. J Pediatr 173:160-164.e
Tada T, Iijima H, Kobayashi N et al (2019) Usefulness of attenuation imaging with an ultrasound scanner for the evaluation of hepatic steatosis. Ultrasound Med Biol 45:2679–2687
Hsu PK, Wu LS, Yen HH et al (2021) Attenuation imaging with ultrasound as a novel evaluation method for liver steatosis. J Clin Med 10:965
Lee DH, Cho EJ, Bae JS et al (2021) Accuracy of two-dimensional shear wave elastography and attenuation imaging for evaluation of patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 19:797-805.e7
Tada T, Kumada T, Toyoda H et al (2020) Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: a comparison with magnetic resonance imaging-determined proton density fat fraction. Hepatol Res 50:1319–1327
Kwon EY, Kim YR, Kang DM et al (2021) Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography. Clin Imaging 76:53–59
Ferraioli G, Maiocchi L, Raciti MV et al (2019) Detection of liver steatosis with a novel ultrasound-based technique: a pilot study using MRI-derived proton density fat fraction as the gold standard. Clin Transl Gastroenterol 10:e00081
Acknowledgements
The authors would like to thank Canon Medical Systems Corporation (Shimoishigami, Otawara-shi, Tochigi, Japan) for the 6 months of software support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The previously published Fig 2b legend stated: "Please note that the bottom bar chart shows the mean R2 value of water, which correlates with hepatic iron content."
This was an error and the sentence should read: "Please note that the bottom bar chart shows the mean R2* value of water, which correlates with hepatic iron content."
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bulakci, M., Ercan, C.C., Karapinar, E. et al. Quantitative evaluation of hepatic steatosis using attenuation imaging in a pediatric population: a prospective study. Pediatr Radiol 53, 1629–1639 (2023). https://doi.org/10.1007/s00247-023-05615-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-023-05615-8